ATC
Graniteshares Autocallable Coin ETF
Set alert
21.59 USD -1.40 -6.09%
21.59 Day range 21.59
19.96 52-week range 25.26
- YTD
- -12.88%
- 1 year
- -12.88%
- Open
- 21.59
- Prev close
- 22.99
- Mkt cap
- 933.91K
- Vol
- 128
- Avg vol
- 264
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 21.59
- High
- 21.59
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2022
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Aug 9, 2022
Expected Aug 9, 2022. Consensus EPS estimate 0.00.
Financials — quick view
ATC Revenue — quarterly 358.10M
ATC Net income — quarterly 23.60M
ATC EPS — quarterly 0.12
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 9, 2022 | Jun 1, 2022 | 0.00 | — | — | — |
| May 11, 2022 | Mar 1, 2022 | 0.00 | — | — | — |
| Apr 4, 2022 | Dec 1, 2021 | 0.00 | — | — | — |
| Nov 9, 2021 | Sep 1, 2021 | 0.27 | — | — | — |
| Aug 11, 2021 | Jun 1, 2021 | 0.13 | — | — | — |
| May 4, 2021 | Mar 1, 2021 | 0.09 | — | — | — |
News
- ATERRA Metals Announces Upsize of Brokered Life Offering to $8,355,000
- ATERRA Metals Announces Brokered Life Offering for up to $6 Million
- ATERRA Metals Reports Maiden Totora Cu-Au Project
- WEC Energy Group Inc (WEC) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and Robust Capital Plan Amid Data Center Demand
- ATERRA Reports Totora Cu/Au Project Drilling Returns 284 m Grading 0.64% CuEq Including 180 m at 0.71% CuEq
- GraniteShares Announces Monthly Distributions for its Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA
- CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
- Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026
- Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress
- Verici Dx Collaborators to Present Data on Predictive Value of Tutivia™ for Acute Kidney Transplant Rejection at ATC 2026
Your note
Sign in to keep a note on ATC — it syncs with the Stock Master app.